AU5667998A - New derivatives of erythromycin, a method for preparing them, and their use as medicines - Google Patents

New derivatives of erythromycin, a method for preparing them, and their use as medicines

Info

Publication number
AU5667998A
AU5667998A AU56679/98A AU5667998A AU5667998A AU 5667998 A AU5667998 A AU 5667998A AU 56679/98 A AU56679/98 A AU 56679/98A AU 5667998 A AU5667998 A AU 5667998A AU 5667998 A AU5667998 A AU 5667998A
Authority
AU
Australia
Prior art keywords
erythromycin
medicines
preparing
new derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU56679/98A
Other versions
AU726147B2 (en
Inventor
Constantin Agouridas
Jean-Francois Chantot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Hoechst Marion Roussel
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel
Publication of AU5667998A publication Critical patent/AU5667998A/en
Application granted granted Critical
Publication of AU726147B2 publication Critical patent/AU726147B2/en
Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. Alteration of Name(s) in Register under S187 Assignors: HOECHST MARION ROUSSEL
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU56679/98A 1996-12-23 1997-12-22 New derivatives of erythromycin, a method for preparing them, and their use as medicines Ceased AU726147B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/15830 1996-12-23
FR9615830A FR2757518B1 (en) 1996-12-23 1996-12-23 NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
PCT/FR1997/002380 WO1998028316A1 (en) 1996-12-23 1997-12-22 Novel erythromycin derivatives, method of preparation and application as medicines

Publications (2)

Publication Number Publication Date
AU5667998A true AU5667998A (en) 1998-07-17
AU726147B2 AU726147B2 (en) 2000-11-02

Family

ID=9498984

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56679/98A Ceased AU726147B2 (en) 1996-12-23 1997-12-22 New derivatives of erythromycin, a method for preparing them, and their use as medicines

Country Status (24)

Country Link
EP (1) EP0946580B1 (en)
JP (2) JP4522496B2 (en)
KR (1) KR20000062286A (en)
CN (1) CN1246123A (en)
AP (1) AP9901566A0 (en)
AT (1) ATE215553T1 (en)
AU (1) AU726147B2 (en)
BR (1) BR9713618A (en)
CA (1) CA2275359A1 (en)
CZ (1) CZ293732B6 (en)
DE (1) DE69711689T2 (en)
DK (1) DK0946580T3 (en)
EA (1) EA199900589A1 (en)
ES (1) ES2172827T3 (en)
FR (1) FR2757518B1 (en)
HU (1) HUP0001452A3 (en)
ID (1) ID21883A (en)
IL (1) IL130510A0 (en)
NO (1) NO993124L (en)
PL (1) PL334134A1 (en)
PT (1) PT946580E (en)
SK (1) SK83199A3 (en)
TR (1) TR199901452T2 (en)
WO (1) WO1998028316A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757518B1 (en) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
YU44900A (en) 1998-01-31 2003-01-31 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
US6720308B1 (en) * 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
JPH0853355A (en) * 1994-08-12 1996-02-27 Taisho Pharmaceut Co Ltd Il-5 production-inhibiting agent
CA2235681A1 (en) * 1995-11-08 1997-05-15 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins a and b
DK0922050T3 (en) * 1996-05-07 2003-11-24 Abbott Lab 3-descladinose-2,3-anhydroerythromycin derivatives
FR2757518B1 (en) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS

Also Published As

Publication number Publication date
KR20000062286A (en) 2000-10-25
CA2275359A1 (en) 1998-07-02
JP5188520B2 (en) 2013-04-24
WO1998028316A1 (en) 1998-07-02
JP2010132683A (en) 2010-06-17
NO993124D0 (en) 1999-06-23
DE69711689T2 (en) 2002-10-17
HUP0001452A3 (en) 2000-10-30
ID21883A (en) 1999-08-05
CZ227999A3 (en) 1999-10-13
NO993124L (en) 1999-08-20
ATE215553T1 (en) 2002-04-15
EP0946580B1 (en) 2002-04-03
PT946580E (en) 2002-09-30
PL334134A1 (en) 2000-02-14
AU726147B2 (en) 2000-11-02
EP0946580A1 (en) 1999-10-06
JP2001507011A (en) 2001-05-29
DK0946580T3 (en) 2002-07-22
JP4522496B2 (en) 2010-08-11
SK83199A3 (en) 2000-05-16
CZ293732B6 (en) 2004-07-14
IL130510A0 (en) 2000-06-01
HU0001452B (en) 2000-09-28
DE69711689D1 (en) 2002-05-08
BR9713618A (en) 2000-04-11
CN1246123A (en) 2000-03-01
AP9901566A0 (en) 1999-06-30
EA199900589A1 (en) 2000-02-28
ES2172827T3 (en) 2002-10-01
FR2757518B1 (en) 1999-06-11
FR2757518A1 (en) 1998-06-26
TR199901452T2 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
AU2310795A (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs
AU2449995A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
AU1929897A (en) Novel erythromycin derivatives, method for preparing same, and use thereof as drugs
AU6991096A (en) New derivatives of 5-0-desosaminyl 6-0-methyl erythronolide A, their preparation process and their use for the preparation of biologically-active products
HUP9900056A2 (en) 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
HRP20010335B1 (en) Novel erythromycin derivatives, preparation method and use as medicines
AU684430B2 (en) Chromone derivative, process for preparing same and pharmaceutical composition
AU1369997A (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
AU7577396A (en) New preparation process for phenylimidazolidine derivatives
AU4071095A (en) Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
AU2393397A (en) Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU4946896A (en) Novel bi-tryptaminic derivatives, preparation process and utilization as drugs
HUP0001245A3 (en) Novel erythromycin derivatives, method of preparation and application as medicines
AU5487798A (en) New derivatives of erythromycin, their preparation process and their use as medicaments
AU5667998A (en) New derivatives of erythromycin, a method for preparing them, and their use as medicines
HUP9800472A3 (en) New benzoxazinedion derivatives, process for producing them and pharmaceutical copositions containing them
AU7847298A (en) Novel substituted 3H -benzoxazole-2-thiones and 3H -benzothiazole-2thi ones derivatives, method for preparing them and pharmaceutical comp ositions containing them
AU4560597A (en) Novel diarylmethylene derivatives, method for preparing and therapeutic uses thereof
EP0778278B1 (en) Alkoxyformoxysilanes, process for their preparation and their use
AU4722996A (en) Epipodophyllotoxin triaryloxyacetyl derivatives, method for preparing same, and use of said derivatives as cancer drugs
AU4706397A (en) Method for producing 1,8-diaminonaphthalines and their 2,3-dihydroperimidine derivatives
AU4882796A (en) Novel sulphonamide bi-tryptamine derivatives, method for preparing same, and use of said derivatives as drugs
AU2886197A (en) New leukotriene-b4 derivatives, their preparation process and their use as medicaments

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: AVENTIS PHARMA S.A.

Free format text: FORMER OWNER WAS: HOECHST MARION ROUSSEL